Literature DB >> 26485172

Variation in attrition at subnational level: review of the Botswana National HIV/AIDS Treatment (Masa) programme data (2002-2013).

Mansour Farahani1, Natalie Price1, Shenaaz El-Halabi2, Naledi Mlaudzi2, Koona Keapoletswe2, Refeletswe Lebelonyane2, Ernest Benny Fetogang2, Tony Chebani2, Poloko Kebaabetswe3, Tiny Masupe3, Keba Gabaake3, Andrew Auld4, Oathokwa Nkomazana3, Richard Marlink1.   

Abstract

OBJECTIVE: To evaluate the variation in all-cause attrition [mortality and loss to follow-up (LTFU)] among HIV-infected individuals in Botswana by health district during the rapid and massive scale-up of the National Treatment Program.
METHODS: Analysis of routinely collected longitudinal data from 226 030 patients who received ART through the Botswana National HIV/AIDS Treatment Program across all 24 health districts from 2002 to 2013. A time-to-event analysis was used to measure crude mortality and loss to follow-up rates (LTFU). A marginal structural model was used to evaluate mortality and LTFU rates by district over time, adjusted for individual-level risk factors (e.g. age, gender, baseline CD4, year of treatment initiation and antiretroviral regimen).
RESULTS: Mortality rates in the districts ranged from the lowest 1.0 (95% CI 0.9-1.1) in Selibe-Phikwe, to the highest 5.0 (95% CI 4.0-6.1), in Mabutsane. There was a wide range of overall LTFU across districts, including rates as low as 4.6 (95% CI 4.4-4.9) losses per 100 person-years in Ngamiland, and 5.9 (95% CI 5.6-6.2) losses per 100 person-years in South East district, to rates as high as 25.4 (95% CI 23.08-27.89) losses per 100 person-years in Mabutsane and 46.3 (95% CI 43.48-49.23) losses per 100 person-years in Okavango. Even when known risk factors for mortality and LTFU were adjusted for, district was a significant predictor of both mortality and LTFU rates.
CONCLUSION: We found statistically significant variation in attrition (mortality and LTFU) and data quality among districts. These findings suggest that district-level contextual factors affect retention in treatment. Further research needs to investigate factors that can potentially cause this variation.
© 2015 John Wiley & Sons Ltd.

Entities:  

Keywords:  zzm321990ARTzzm321990; zzm321990HIVzzm321990; zzm321990TARzzm321990; zzm321990VIHzzm321990; Botswana; abandono; antiretroviral therapy; attrition; marginal structural model; modelo estructural marginal; modèle structurel marginal; multilevel; multinivel; à plusieurs niveaux

Year:  2015        PMID: 26485172      PMCID: PMC4834839          DOI: 10.1111/tmi.12623

Source DB:  PubMed          Journal:  Trop Med Int Health        ISSN: 1360-2276            Impact factor:   2.622


  19 in total

Review 1.  Inequalities in health care use and expenditures: empirical data from eight developing countries and countries in transition.

Authors:  M Makinen; H Waters; M Rauch; N Almagambetova; R Bitran; L Gilson; D McIntyre; S Pannarunothai; A L Prieto; G Ubilla; S Ram
Journal:  Bull World Health Organ       Date:  2000       Impact factor: 9.408

2.  Estimating the causal effect of zidovudine on CD4 count with a marginal structural model for repeated measures.

Authors:  Miguel A Hernán; Babette A Brumback; James M Robins
Journal:  Stat Med       Date:  2002-06-30       Impact factor: 2.373

3.  The World Health Report 2006: working together for health.

Authors:  J-J Guilbert
Journal:  Educ Health (Abingdon)       Date:  2006-11

4.  The real challenges for scaling up ART in sub-Saharan Africa.

Authors:  Wim Van Damme; Katharina Kober; Marie Laga
Journal:  AIDS       Date:  2006-03-21       Impact factor: 4.177

5.  Strengthening the HIV cascade to ensure an effective future ART response in sub-Saharan Africa.

Authors:  Darshini Govindasamy; Katharina Kranzer; Nathan Ford
Journal:  Trans R Soc Trop Med Hyg       Date:  2013-11-26       Impact factor: 2.184

6.  Relation of pooled logistic regression to time dependent Cox regression analysis: the Framingham Heart Study.

Authors:  R B D'Agostino; M L Lee; A J Belanger; L A Cupples; K Anderson; W B Kannel
Journal:  Stat Med       Date:  1990-12       Impact factor: 2.373

7.  Effects of state-level public spending on health on the mortality probability in India.

Authors:  Mansour Farahani; S V Subramanian; David Canning
Journal:  Health Econ       Date:  2010-11       Impact factor: 3.046

8.  The influence of sex, race/ethnicity, and educational attainment on human immunodeficiency virus death rates among adults, 1993-2007.

Authors:  Edgar P Simard; Mesfin Fransua; Deepa Naishadham; Ahmedin Jemal
Journal:  Arch Intern Med       Date:  2012-11-12

9.  Constructing inverse probability weights for marginal structural models.

Authors:  Stephen R Cole; Miguel A Hernán
Journal:  Am J Epidemiol       Date:  2008-08-05       Impact factor: 4.897

10.  Widening Socioeconomic, Racial, and Geographic Disparities in HIV/AIDS Mortality in the United States, 1987-2011.

Authors:  Gopal K Singh; Romuladus E Azuine; Mohammad Siahpush
Journal:  Adv Prev Med       Date:  2013-05-07
View more
  4 in total

1.  Attrition from antiretroviral treatment services among pregnant and non-pregnant patients following adoption of Option B+ in Haiti.

Authors:  Jean Wysler Domercant; Nancy Puttkammer; Paul Young; Krista Yuhas; Kesner François; Reynold Grand'Pierre; David Lowrance; Michelle Adler
Journal:  Glob Health Action       Date:  2017       Impact factor: 2.640

2.  Retention Throughout the HIV Care and Treatment Cascade: From Diagnosis to Antiretroviral Treatment of Adults and Children Living with HIV-Haiti, 1985-2015.

Authors:  Andrew F Auld; Ermane G Robin; Ray W Shiraishi; Jacob Dee; Mayer Antoine; Yrvel Desir; Gracia Desforges; Chris Delcher; Nirva Duval; Nadjy Joseph; Kesner Francois; Mark Griswold; Jean Wysler Domercant; Yves Anthony Patrice Joseph; Joelle Deas Van Onacker; Varough Deyde; David W Lowrance
Journal:  Am J Trop Med Hyg       Date:  2017-10       Impact factor: 2.345

3.  Impact of Health System Inputs on Health Outcome: A Multilevel Longitudinal Analysis of Botswana National Antiretroviral Program (2002-2013).

Authors:  Mansoor Farahani; Natalie Price; Shenaaz El-Halabi; Naledi Mlaudzi; Koona Keapoletswe; Refeletswe Lebelonyane; Ernest Benny Fetogang; Tony Chebani; Poloko Kebaabetswe; Tiny Masupe; Keba Gabaake; Andrew F Auld; Oathokwa Nkomazana; Richard Marlink
Journal:  PLoS One       Date:  2016-08-04       Impact factor: 3.240

4.  Outcomes after antiretroviral therapy during the expansion of HIV services in Haiti.

Authors:  Margaret L McNairy; Patrice Joseph; Michelle Unterbrink; Stanislas Galbaud; Jean-Edouard Mathon; Vanessa Rivera; Deanna Jannat-Khah; Lindsey Reif; Serena P Koenig; Jean Wysler Domercant; Warren Johnson; Daniel W Fitzgerald; Jean W Pape
Journal:  PLoS One       Date:  2017-04-24       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.